Durvalumab-Induced Diffuse Alveolar Hemorrhage: An Autopsy Case Report

Durvalumab, a programmed cell death ligand 1 inhibitor, induces various immune-related adverse events (irAEs), including lung injury. However, diffuse alveolar hemorrhage (DAH) is a rare type of lung injury due to immune checkpoint inhibitors. A 76-year-old man with c-stage IIIA squamous cell carcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanaoka, Kensuke, Ikebe, Saori, Ihara, Shouichi, Tsuji, Hiromi, Yasuoka, Hironao, Minami, Seigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383190/
https://www.ncbi.nlm.nih.gov/pubmed/32774259
http://dx.doi.org/10.1159/000507848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383190/
https://www.ncbi.nlm.nih.gov/pubmed/32774259
http://dx.doi.org/10.1159/000507848

Ejemplares similares